Arcutis Biotherapeutics, Inc. (ARQT)

Arcutis Biotherapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 21, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	3,271	1,630	305	901	1,043	1,225
Market Cap Growth	91.13%	434.82%	-66.18%	-13.58%	-14.88%	-
Enterprise Value	3,193	1,508	283	626	681	1,039
Last Close Price	26.70	13.93	3.23	14.80	20.74	28.13
PS Ratio	10.62	8.30	5.11	244.56	-	-
PB Ratio	20.32	10.35	3.44	4.30	3.50	4.53
P/TBV Ratio	22.92	11.01	3.71	4.45	3.50	4.53
EV/Sales Ratio	10.04	7.67	4.75	169.88	-	-
Debt / Equity Ratio	0.72	0.70	2.32	0.97	0.26	0.02
Asset Turnover	0.79	0.57	0.15	0.01	-	-
Inventory Turnover	1.75	1.38	0.48	-	-	-
Quick Ratio	3.07	3.72	6.38	11.06	11.61	12.61
Current Ratio	3.50	4.14	7.08	11.57	12.09	12.96
Return on Equity (ROE)	-28.17%	-113.76%	-175.79%	-122.80%	-72.62%	-72.93%
Return on Assets (ROA)	-5.91%	-23.25%	-38.12%	-43.97%	-36.55%	-42.14%
Return on Capital Employed (ROCE)	-14.10%	-47.90%	-81.80%	-73.30%	-55.10%	-49.60%
Earnings Yield	-1.36%	-8.59%	-85.99%	-34.55%	-19.78%	-11.07%
FCF Yield	-1.02%	-6.89%	-81.18%	-28.63%	-16.84%	-9.25%
Buyback Yield / Dilution	-11.93%	-74.53%	-25.94%	-11.39%	-38.52%	-1835.11%

Updated Oct 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q